Pharmaceutical industry – Page 57
-
OpinionWe need more surprises
Who's that asleep at the back? Don't be too quick to blame yourself when tedious talks and soporific seminars fail to inspire, says Derek Lowe
-
OpinionThe 'blockbuster mentality’
Should companies focus on big markets and the blockbuster dream? The more modern approaches are not without risks, says Derek Lowe
-
OpinionThe quiet comeback of 'combi-chem'
Derek Lowe investigates the comeback combinatorial chemistry has made in the field of drug discovery
-
Opinion
How much selectivity do you want?
Derek Lowe considers the quandaries of living in the age of the kinase
-
Opinion
Missing methods
Derek Lowe reminisces about lost laboratory techniques and wonders which will be next to go
-
Opinion
If something can’t go on, then it won’t
Derek Lowe looks into his crystal ball to see what the future of medicinal chemistry might be
-
OpinionDeath by assay result
Derek Lowe wonders whether tagging molecules with fluorescent labels for assay is like tracking the members of a shoal of fish by tying each one to a whale
-
Opinion
How to be an organised scientist
Derek Lowe waxes lyrical about the joys of the electronic lab notebook
-
Opinion
Papers vs patents
Derek Lowe wonders whether peer-reviewed papers or patents are more reliable
-
Opinion
The sincerest form of flattery
Is the pharmaceutical industry churning out copycat versions of existing therapies? Derek Lowe dispels a few myths about 'me-too' drugs
-
Opinion
Senseless screening
Derek Lowe advises opening your mind during the screening cascade taken by potential drug targets, and remaining goal orientated at all times
-
Opinion
Reliable reactions
Derek Lowe discusses the problem of leaning too heavily on favourite reactions
-
Opinion
Difficult diseases to drug
Derek Lowe wonders why some diseases are easier to drug than others
-
Opinion
Beautiful chemistry
Derek Lowe considers what makes a good looking drug molecule - and how beauty is in the eye of the beholder
-
Opinion
Formulation chemist friction
Derek Lowe wonders where we'd be without the formulation chemists
-
Opinion
Collaborative compromise
Derek Lowe wonders about pharmaceutical companies' motives for collaboration
-
Opinion
Prescription unknowns
Derek Lowe considers what we think we know about how drugs work once we've taken them